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Objective: To evaluate clinically, and with laboratory, tests, women with polycystic ovary syndrome (PCO). Patients: One hundred
and twelve women with PCO were studied. Methods: The following data was recorded: Current age; age at menarche; menstrual
irregularity, occurrence of similar cases in the family; fertility, obstetric history; body mass index (8MI); and presence of hirsutism.
Serum measurements of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, free testosterone, and
dehydroepiandrosterone sulfate were taken. Results: All patients presented either oligomenorrhea (31 percent), periods of second-
ary amenorrhea (9 percent), or both alterations (60 percent). The majority of the patients were infertile (75.6 percent). The LH/FSH
ratio was higher than 2:1 in 55 percent of the patients and higher than 3:1 in 26.2 percent. The ultrasonographic aspect of the ovaries~:
was considered to be normal in 31 percent. Conclusion: The main clinical feature of the PCO is the irregularity of menses since
menarche, and that the laboratory tests would be important to exclude other disorders such as hyperprolactinemia or hyperandrogenemia
caused by late-onset congenital adrenal hyperplasia.
UNITERMS: Polycystic Ovary syndrome. Oligomenorrhea. Secondary amenorrhea.
INTRODUCTION
Polycystic ovary syndrome (PCa) was first described
by Stein and Leventhal in 1935 in women presenting
oligomenorrhea, hirsutism, obesity, and enlarged
polycystic ovaries. I However, some of these characteristics
may not be present in the syndrome.
Many theories have been advanced to explain the
physiopathology of pca,2-4 but its etiology continues to
elude gynecologists and endocrinologists.3 In the present
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study we evaluated the clinical characteristics and
laboratory findings most frequently detected in the
syndrome.
MATERIAL AND METHODS
A retrospective study was conducted on 112 women
with pca followed up at the Division of Gynecological
Endocrinology, Department of Gynecology, Escola
Paulista de Medicina, Universidade Federal de Sao Paulo.
All patients were submitted to detailed clinical and
gynecological examinations supplemented with plasma
hormone measurements. and pelvic ultrasound (PUS).
Current age, age at menarche, menstrual irregularity,
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occurrence of similar cases in the family, fertility, obstetric
history, body mass index (BMI), and presence or absence
of hirsutism were recorded. The last parameter was
evaluated by the index of Ferriman and Gallwey (IFG).5
Women were considered to be hirsute when their IFG was
6 or above.
Serum measurements of follicle stimulating hormone
(FSH),6Iuteinizing hormone (LH),6 prolactin (PRL),7 free
testosterone (free T),l! and dehydroepiandrosterone sulfate
(DHEAS), 'J were performed by radioimmunoassay.
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31%
enlarged
17% micropolycystic
21%
RESULTS
The age of the patients ranged from 16 to 32 years
(mean:tstandard deviation [SD] 22.3:t4.0). The age at
menarche was from 9 to 18 years (mean 13.3:t2.0). The
age of onset of menstrual irregularity was from 10 to 24
(mean 13.9:t2.5). Menstrual alteration had occurred since
menarche in 84 percent of the cases.
Figure I illustrates the menstrual pattern of the
patients. All of them presented either oligomenorrhea,
periods of secondary amenorrhea, or both alterations.
Similar cases in their families were reported by 25.7
percent of the patients. It is interesting to note that 5.3
percent of the women reported that their mothers presented
the same clinical picture.
A large majority of the women had never been
pregnant (90.2 percent). Only 7.1 percent had had one
pregnancy, and the other 2.7 percent had had two or more
pregnancies. Infertility was present in 75.6 percent of the
women.
The mean BMI value was 23.84:t5.25. Obesity
(BMI>25) was observed in 29.4 percent of patients, and
hirsutism (IFG~6) in 17.9 percent.
oligomenorrhea
31%
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and secondary
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60%
secondary
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Figure 1 - Menstrual pattern of the patients.
Figure 2 - Ultrasonographic aspect of the ovaries.
Mean (:tSD) serum values ofLH, FSH, PRL, free T,
DHEAS, and of the LHiFSH ratio are shown in Table I. It
can be seen that the LHIFSH ratio was~3: I in 26.2 percent
of patients, and ~2: I in 55.0 percent. Only 14.9 percent of
the patients had hyperprolactinemia (PR~20 ng/ml).
Figure 2 shows the ultrasonographic aspect of the
ovaries, considered normal in 31.0 percent of the patients.
DISCUSSION
It is generally accepted that PCO may start early in
the reproductive life of women, perhaps even before
menarche. III The theory of adrenarche suggests that the
reticular zone of the adrenal may be inappropriately
stimulated, causing an increase in androgen levels, which
in turn may lead to an increased extraglandular estrogen
production.4
Other investigators, however, consider the central
nervous system to be the initial causal factor of PCO.2 In
this case, a decrease in hypothalamic opiods and
dopaminergic tonus may lead to an increase in pulsatile
gonadotropin releasing hormone (GnRH) secretion by the
hypothalamus, with a consequent alteration in
gonadotropin secretion. Inappropriate gonadotropin
secretion with an increased LH/FSH ratio may lead to
hyperandrogenemia, micropolycystic ovaries and
increased peripheral conversion of androgens to estrogens,
especially of androstenedione to estrone. High estrone
levels and normal estradiol levels may promote
inappropriate gonadotropin secretion by increasing the
sensitivity of pituitary LH to GnRH, with the consequent
occurrence of a vicious cycle.2. II
The major characteristic of PCO is chronic
anovulation, which in our series was reflected by
oligomenorrhea and/or secondary amenorrhea. This
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however, believe that both conditions
may be related to an increase in'LHI
FSH ratio and to a decrease in
dopaminergic tonus.17 Hyperpro-
DHEASII lactinemia is estimated to occur in
approximately 25 percent of women
with PCO.IX Our findings differ
considerably from those reported in
the literature, since we detected this
association in only 14.9 percent of the
patients. This discrepancy may
perhaps be explained by the different
methodologies adopted to measure
plasma prolactin. In our opinion, however, the
determination of this hormone is still imperative in all
women with PCO.
Androgen production is increased in patients with
PCO compared to normal women, with plasma testosterone
levels being elevated in only 50 percent of these patients.
This discrepancy is explained in part by the reduced
binding ability of sex hormone binding globulin (SHBG),
and the consequent increase in the metabolic rate of
testosterone clearance, since there is more free T in
plasma. II) Surprisingly, we did not detect high levels of
free T or DHEAS in our cases. Several studies have shown
that plasma androgen levels are usually normal, even in
hirsute women.2()
In 69 percent of our patients; we detected an increased
ovarian volume andlor the presence of micropolycysts inside
the ovaries by PUS. This means that 31 percent of the
patients had normal ovaries when examined by PUS. These
data suggest that the presence of enlarged and
micropolycystic ovaries is frequently detected by PUS, but
that their absence does not exclude the diagnosis of PCO.
Ultrasonography is particularly useful in borderline cases
with suggestive clinical histories, which do not present, for
example, changes in the LHIFSH ratio.21
On the basis of our results, we may conclude that
the clinical history continues to be the major weapon for
the diagnosis ofPCO. The most important clinical finding
is the i rregu Iari ty of menses, since men arche is
characterized by oligomenorrhea and/or secondary'
amenorrhea. Auxiliary tests such as the determination of
the LH/FSH ratio would be important to confirm the
diagnosis, or to exclude other disorders (such as
hyperprolactinemia or hyperandrogenemia) caused by
enzymatic defects of the adrenal glands, or by functioning
ovarian or adrenal tumors.
T livre9
2.4:t0.9
PRL:f:
14.0:t8.2
LH/FSH
2.3:t1.3
FSHt
12.2:t6.9
Table 1
Mean (SO) serum values of LH (U/L) FSH (U/L) PRL (ng/mL) LH/FSH
ratio free T (pg/mL) and DHEAS (llg/dL)
chronic anovulation also explains the high incidence of
infertility detected here.
Several studies have shown a higher prevalence of
the syndrome up to 25 years of age. In our series, the
women were also young, with SO percent of them being
less than 25 years old, and presenting irregular menses
that started soon after menarche.
Obesity has been associated with PCO since the
syndrome was first described, I and was present in 29.7
percent of our patients. These data coincide with those
reported in the literature, which reveals an incidence of
30 to 50 percent. 12 The role of obesity in the genesis of the
syndrome is still unclear. However, it has been
demonstrated that in some women with PCO, weight loss
reduces estrone levels, gonadotropi n secretion, and
normalizes the menses.3
It has been reported that 50 to 70 percent of patients
with PCO have hirsutism.12• 13 Only IS percent of our
patients had hirsutism, and the phenomenon was mild in
most of them (IFG<S). This result, which disagrees with
the literature, shows that the prevalence of hirsutism was
not relevant in our sample, and was only slightly higher
than in the general population.14
It is interesting that 25.7 percent of our patients reported
a similar case in their family, a fact perhaps suggesting a
genetic alteration, although this cannot be proved.
We detected an LHiFSH ratio higher than 2 in 55
percent of the patients, and higher than 3 in 26.2 percent.
These data show that inappropriate LH secretion in PCO 2
is not necessarily accompanied by an increase in plasma
LHIFSH ratio.
The association of hyperprolactinemia with PCO
was noted a long time ago. Some investigators, however,
consider it to be a random occurrence because of the
relative frequency of the two disorders. IS. l(j Others,
LH*
23.9:t14.7
* Normal values in women during follicular phase range from 1.5 to 10.0 U/L.
t Normal values in women during follicular phase range from 2.9 to 12.0 U/L.
:f: Normal values in women are up 20 ng/ml.
9 Normal values in women range from 0.2 to 3.2 pg/ml.
II Normal values in women range from 50 to 340 (Ilg/dl).
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RESUMO
Objetivos: Avaliar c1inica e laboratorialmente mulheres com a sindrome dos ovarios policisticos (SOP). Pacientes: Foram
estudadas 112 mulheres com SOP Metodos: Avaliamos idade, idade da menarca, historia menstrual, epoca do aparecimento
da irregularidade menstrual, ocorrencia de casos semelhantes na familia, antecedentes obstetricos, fndice de massa corporea,
e presenc;a de hirsutismo. Foram realizadas as dosagens sericas de hormonio foliculo-estimulante (FSH), tlormonio luteinizante
(LH), prolactina, testosterona livre e de sulfato de dehidroepiandrosterona. Resultados: Todas as multleres apresentavam
espaniomenorreia (31 percent), periodos de amenorreia secunda ria (9 percent) ou ambas alterac;oes (60 percent). A maioria
era infertil (75,6 percent). A relac;ao LH/FSH era maior que 3 em 26,2 percent e maior que 2 em 55,0 percent das mulheres. a
aspecto ultra-sonografico dos ovarios era normal em 31 percent das mulheres. ConciLfSao: A principal caracteristica clinica
da SOP e a irregularidade menstrual desde a menarca e os exames de laboratorio seriam importantes para afastar outras
patologias como as sindromes hiperprolactinemicas ou as deficiencias enzimaticas tardias da supra-renal.
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